Top rated breast cancer clinical trials in Raleigh, North Carolina
Here are the top 10 medical studies for breast cancer in Raleigh, North Carolina
Popular filter options for breast-cancer raleigh trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Procedure
Surgery or High-Dose Radiation for Metastatic Breast Cancer
Recruiting1 awardPhase 2 & 3
Raleigh, North Carolina
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Anti-metabolites
High-Dose Methotrexate for Breast Cancer
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial is testing the use of high-dose methotrexate to treat leptomeningeal disease (LMD) in patients with metastatic breast cancer. LMD is a cancer that has spread to the thin layer of tissue that covers the brain and spinal cord. There is no cure for LMD, and it is a difficult disease to treat because it is hard to reach with traditional cancer treatments. HD-MTX is a chemotherapy drug that has been shown to be effective against breast cancer, and it is hoped that it will be effective against LMD as well. This study is being done to see if HD-MTX is
Hormone Therapy
Telephone Support for Breast Cancer Treatment Adherence
Recruiting1 award8 criteria
Goldsboro, North Carolina
This trial studies a telephone intervention to see if it increases adherence to adjuvant hormonal therapy in patients with breast cancer. The intervention may help to increase doctor-patient communication and patients' adherence to their prescribed medication.
Procedure
Surgery or High-Dose Radiation for Metastatic Breast Cancer
Recruiting1 awardPhase 2 & 3
Raleigh, North Carolina
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Selective Estrogen Receptor Downregulator
Fulvestrant +2 More for Breast Cancer
Recruiting1 awardPhase 2
Chapel Hill, North Carolina
This trial is studying whether fulvestrant is more effective than anastrozole or tamoxifen in reducing Ki67 in ILC and whether that Ki67 reduction will correlate with alterations in expression of ER and ER-regulated genes.
View More Breast-cancer Raleigh Trials
See another 84 medical studies focused on breast-cancer raleigh.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.